Valeant’s Deal for Salix Continues Frenzied Deal-Making in Drug Sector ROBERT CYRAN There is relief among Valeant’s backers that the company has returned to signing deals, after its long chase of Allergan left it empty-handed. February 24, 2015 at 12:00AM http://nyti.ms/1B5UNKV The New York Times Business Day Mergers, Acquisitions and Divestitures, Drugs (Pharmaceuticals)

By ROBERT CYRAN via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1B5UNKV Valeant’s Deal for Salix Continues Frenzied Deal-Making in Drug Sector February 24, 2015 at 12:00AM The New York Times